MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ando.2026.102557

Медицинская библиотека · Annales d'endocrinologie · 2026

Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.

Faivre Laurence, Level Camille, Coutant Régis, Rodien Patrice, Barlier Anne, Saveanu Alexandru, Bouvattier Claire, Bretones Patricia, Martinerie Laetitia, Rossignol Sylvie, Lenelle Camille, Roucher Florence, Binquet Christine, Pasquier Laurent, Davoine Emeline, Cormier Coline, Bournez Marie, Maudinas Raphaelle, Gonnot Maxime, Lefevre Augustin, Maraval Julien, Safraou Hana, Duffourd Yannis, Bellanné-Chantelot Christine, Saint-Martin Cécile, Bergougnoux Anne, Mallet Delphine, Bouligand Jérôme, de Roux Nicolas, Coppin Lucie, Diene Gwenaelle, Poitoux Christine, Prunier Delphine, Dieu Xavier, Burnichon Nelly, Christin-Maitre Sophie, Jaillard Sylvie, Launay Erika, Rabès Jean-Pierre, Benlian Pascale, Di Filippo Mathilde, Marmontel Oriane, Bernert Christine Poitou, Vigouroux Corinne, Bismuth Elise, Beltrand Jacques, Polak Michel, Giraud Sophie, Pigny Pascal, Savagner Frédérique, Petit Isabelle Olivier, Arnoux Jean-Baptiste, Beliard Sophie, Odou Marie-Françoise, Romanet Pauline, Molin Arnaud, Apetrei Andreea, Richard Nicolas, Pacot Laurence, Pasmant Eric, Hureaux Marguerite, Vargas Rosa, Gay-Bellile Mathilde, Aouchiche Karine, Carrié Alain, Chauvet Margaux, Gallo Antonio, Lemale Julie, Moulin Philippe, Peretti Noël, Thauvin-Robinet Christel, Huet Frédéric, Tardy-Guidolet Véronique

СтатьяОбзорПеревод в очереди

Аннотация

INTRODUCTION

Genome sequencing (GS) is reshaping newborn screening (NBS) by enabling the early detection of a broader range of rare, treatable and/or actionable disorders. In the context of rapid therapeutic advances, international pilot programs - many coordinated within the International Consortium on Newborn Sequencing (ICoNS) - are evaluating genome-based NBS (gNBS) as a preventive public health strategy.

MATERIALS AND

METHODS

We reviewed published international gNBS pilot studies, with particular attention to discussions related to endocrine disorders. We integrated insights from the French PERIGENOMED-CLINICS 1 (PGC1) project, including its curated gene list and collaboration mainly with the FIRENDO French network dedicated to rare endocrine diseases.

RESULTS

No publications were identified specifically addressing gNBS in rare pediatric endocrine diseases as a unified domain. In comparative analyses of gNBS pilot programs, endocrine disorders represented approximately 10% of included conditions, with marked heterogeneity across initiatives and no primary endocrine disorder uniformly retained. Analysis of the PGC1 dataset identified 125 endocrine and endocrine-adjacent gene-disease dyads (14% of all project dyads), divided into list 1 ("treatable", n=62) and list 2 ("actionable", n=63). List 1 predominantly included early-onset, hormonally driven disorders, whereas list 2 extended toward obesity-related and multisystem syndromic conditions. Stratification by clinical actionability revealed four categories ranging from time-critical neonatal conditions to surveillance-driven and long-term risk phenotypes, underscoring substantial variability in timing of intervention, penetrance, and level of evidence supporting early benefit.

CONCLUSION

Genomic NBS is transforming rare disease management, including endocrine diseases, by enabling earlier diagnosis, precision care, and coordinated professional and family-based interventions, marking a paradigm shift in population health.

Для цитирования: Faivre Laurence, Level Camille, Coutant Régis, Rodien Patrice, Barlier Anne, Saveanu Alexandru, Bouvattier Claire, Bretones Patricia, Martinerie Laetitia, Rossignol Sylvie, Lenelle Camille, Roucher Florence, Binquet Christine, Pasquier Laurent, Davoine Emeline, Cormier Coline, Bournez Marie, Maudinas Raphaelle, Gonnot Maxime, Lefevre Augustin, Maraval Julien, Safraou Hana, Duffourd Yannis, Bellanné-Chantelot Christine, Saint-Martin Cécile, Bergougnoux Anne, Mallet Delphine, Bouligand Jérôme, de Roux Nicolas, Coppin Lucie, Diene Gwenaelle, Poitoux Christine, Prunier Delphine, Dieu Xavier, Burnichon Nelly, Christin-Maitre Sophie, Jaillard Sylvie, Launay Erika, Rabès Jean-Pierre, Benlian Pascale, Di Filippo Mathilde, Marmontel Oriane, Bernert Christine Poitou, Vigouroux Corinne, Bismuth Elise, Beltrand Jacques, Polak Michel, Giraud Sophie, Pigny Pascal, Savagner Frédérique, Petit Isabelle Olivier, Arnoux Jean-Baptiste, Beliard Sophie, Odou Marie-Françoise, Romanet Pauline, Molin Arnaud, Apetrei Andreea, Richard Nicolas, Pacot Laurence, Pasmant Eric, Hureaux Marguerite, Vargas Rosa, Gay-Bellile Mathilde, Aouchiche Karine, Carrié Alain, Chauvet Margaux, Gallo Antonio, Lemale Julie, Moulin Philippe, Peretti Noël, Thauvin-Robinet Christel, Huet Frédéric, Tardy-Guidolet Véronique. Genomic newborn screening as a paradigm shift in rare disease management, with emphasis on endocrine conditions.. Annales d'endocrinologie. 2026. DOI: 10.1016/j.ando.2026.102557.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.